These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38779783)

  • 1. Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge.
    Olivieri B; Gil AJ; Stoenchev K; Durham SR; Scadding G
    Clin Transl Allergy; 2024 May; 14(5):e12360. PubMed ID: 38779783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of controlled exposure to house dust mite in the environmental exposure unit (EEU).
    Hossenbaccus L; Linton S; Thiele J; Steacy L; Walker T; Malone C; Ellis AK
    Allergy Asthma Clin Immunol; 2021 Mar; 17(1):34. PubMed ID: 33771217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH; Xu C; Liu L; Chai RN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.
    Ellis AK; Soliman M; Steacy L; Boulay MÈ; Boulet LP; Keith PK; Vliagoftis H; Waserman S; Neighbour H
    Allergy Asthma Clin Immunol; 2015; 11(1):16. PubMed ID: 25945101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated allergen exposure chamber is plausible tool for the assessment of house dust mite-triggered allergic rhinitis.
    Zemelka-Wiacek M; Kosowska A; Winiarska E; Sobanska E; Jutel M
    Allergy; 2023 Jan; 78(1):168-177. PubMed ID: 35980665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU).
    Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ
    Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal IgE in subjects with allergic and non-allergic rhinitis.
    Eckrich J; Hinkel J; Fischl A; Herrmann E; Holtappels G; Bachert C; Zielen S
    World Allergy Organ J; 2020 Jun; 13(6):100129. PubMed ID: 32612737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual wearable air purifier protects against pollen, house dust mite, and cat allergens: Report from an allergen exposure chamber.
    Bergmann KC; Hartung T; Zuberbier T
    Allergol Select; 2024; 8():70-77. PubMed ID: 38549812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
    Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
    Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ
    Vitiello G; Maltagliati L; Rossi O
    Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber.
    Lueer K; Biller H; Casper A; Windt H; Mueller M; Badorrek P; Haefner D; Framke T; Koch A; Ziehr H; Krug N; Koch W; Hohlfeld JM
    Allergy; 2016 Dec; 71(12):1693-1700. PubMed ID: 27255590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
    Durham SR; Creticos PS; Nelson HS; Li Z; Kaur A; Meltzer EO; Nolte H
    J Allergy Clin Immunol; 2016 Oct; 138(4):1081-1088.e4. PubMed ID: 27527264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
    Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
    Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority.
    Struß N; Dieter S; Schwarz K; Badorrek P; Hohlfeld JM
    Int Arch Allergy Immunol; 2023; 184(11):1143-1152. PubMed ID: 37586347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.